Clinical and economic burden associated with symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy in Germany

Background: The clinical and economic burden of obstructive hypertrophic cardiomyopathy (HCM) in Germany for symptomatic versus asymptomatic patients has not been comprehensively assessed. Methods: This retrospective observational study analyzed nationally representative WIG2 Benchmark Database data...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sedaghat-Hamedani, Farbod (VerfasserIn) , Zema, Carla L. (VerfasserIn) , Schultze, Michael (VerfasserIn) , Garcia, Tarcyane B. (VerfasserIn) , Kossack, Nils (VerfasserIn) , Borchert, Julia (VerfasserIn) , Maksabedian Hernandez, Ervant J. (VerfasserIn) , Zhong, Yue (VerfasserIn) , Bluhmki, Tobias (VerfasserIn) , Krause, Taryn (VerfasserIn) , Schmoelders, Johanna (VerfasserIn) , Meder, Benjamin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 27 October 2025
In: Clinical research in cardiology
Year: 2025, Pages: 1-10
ISSN:1861-0692
DOI:10.1007/s00392-025-02776-4
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00392-025-02776-4
Volltext
Verfasserangaben:Farbod Sedaghat-Hamedani, Carla L. Zema, Michael Schultze, Tarcyane B. Garcia, Nils Kossack, Julia Borchert, Ervant J. Maksabedian Hernandez, Yue Zhong, Tobias Bluhmki, Taryn Krause, Johanna Schmoelders, Benjamin Meder

MARC

LEADER 00000naa a22000002c 4500
001 1944400575
003 DE-627
005 20251204094006.0
007 cr uuu---uuuuu
008 251204s2025 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00392-025-02776-4  |2 doi 
035 |a (DE-627)1944400575 
035 |a (DE-599)KXP1944400575 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sedaghat-Hamedani, Farbod  |d 1984-  |e VerfasserIn  |0 (DE-588)102545488X  |0 (DE-627)722303106  |0 (DE-576)370367138  |4 aut 
245 1 0 |a Clinical and economic burden associated with symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy in Germany  |c Farbod Sedaghat-Hamedani, Carla L. Zema, Michael Schultze, Tarcyane B. Garcia, Nils Kossack, Julia Borchert, Ervant J. Maksabedian Hernandez, Yue Zhong, Tobias Bluhmki, Taryn Krause, Johanna Schmoelders, Benjamin Meder 
264 1 |c 27 October 2025 
300 |b Illustrationen 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 27. Oktober 2025 
500 |a Gesehen am 04.12.2025 
520 |a Background: The clinical and economic burden of obstructive hypertrophic cardiomyopathy (HCM) in Germany for symptomatic versus asymptomatic patients has not been comprehensively assessed. Methods: This retrospective observational study analyzed nationally representative WIG2 Benchmark Database data, identifying adults diagnosed with obstructive HCM from 2012 to 2018. Study index was the first date when a participant met eligibility criteria. An algorithm based on coded symptoms and pharmacological treatments was used to divide patients into symptomatic and asymptomatic subgroups. Annual prevalence, patient characteristics, outcomes, resource utilization, and costs were assessed during follow-up. Results: Overall, 1141 patients were included (649 symptomatic patients and 492 asymptomatic patients during the 1-year pre-index period [baseline]). In total, 1042 patients had symptomatic disease at some point during follow-up. Annual obstructive HCM prevalence increased between 2011 and 2019 and was higher for symptomatic than asymptomatic patients. Compared with asymptomatic patients, symptomatic patients: were older (mean age: 62.8 vs. 55.5 years), were less likely to be male (59% vs. 67%), and had higher Charlson Comorbidity Index (mean: 2.82 vs. 1.69) at baseline; had higher rates of all-cause mortality (0.05 vs. 0.02 per 100 patient-years) and cardiovascular events (mean follow-up: 4.7 years); had more outpatient visits (13.3 vs. 10.8 per patient-year [PPY]), inpatient visits (0.7 vs. 0.5 PPY), and longer mean length of stay (8.7 vs. 7.4 days); and had higher mean costs PPY for outpatient, inpatient, and pharmacy services (total: €5975 vs. €4399).Conclusions: Patients with symptomatic obstructive HCM experienced greater clinical and economic burden than asymptomatic patients in Germany. 
650 4 |a Cardiovascular outcomes 
650 4 |a Clinical and economic burden of illness 
650 4 |a Healthcare costs 
650 4 |a Healthcare resource utilization 
650 4 |a Symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy 
700 1 |a Zema, Carla L.  |e VerfasserIn  |4 aut 
700 1 |a Schultze, Michael  |e VerfasserIn  |4 aut 
700 1 |a Garcia, Tarcyane B.  |e VerfasserIn  |4 aut 
700 1 |a Kossack, Nils  |e VerfasserIn  |4 aut 
700 1 |a Borchert, Julia  |e VerfasserIn  |4 aut 
700 1 |a Maksabedian Hernandez, Ervant J.  |e VerfasserIn  |4 aut 
700 1 |a Zhong, Yue  |e VerfasserIn  |4 aut 
700 1 |a Bluhmki, Tobias  |e VerfasserIn  |4 aut 
700 1 |a Krause, Taryn  |e VerfasserIn  |4 aut 
700 1 |a Schmoelders, Johanna  |e VerfasserIn  |4 aut 
700 1 |a Meder, Benjamin  |e VerfasserIn  |0 (DE-588)135821630  |0 (DE-627)571676316  |0 (DE-576)300664745  |4 aut 
773 0 8 |i Enthalten in  |t Clinical research in cardiology  |d Berlin : Springer, 2006  |g (2025), Seite 1-10  |h Online-Ressource  |w (DE-627)506287343  |w (DE-600)2218331-0  |w (DE-576)251097692  |x 1861-0692  |7 nnas  |a Clinical and economic burden associated with symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy in Germany 
773 1 8 |g year:2025  |g pages:1-10  |g extent:10  |a Clinical and economic burden associated with symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy in Germany 
856 4 0 |u https://doi.org/10.1007/s00392-025-02776-4  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20251204 
993 |a Article 
994 |a 2025 
998 |g 135821630  |a Meder, Benjamin  |m 135821630:Meder, Benjamin  |d 910000  |d 910100  |e 910000PM135821630  |e 910100PM135821630  |k 0/910000/  |k 1/910000/910100/  |p 12  |y j 
998 |g 102545488X  |a Sedaghat-Hamedani, Farbod  |m 102545488X:Sedaghat-Hamedani, Farbod  |d 910000  |d 910100  |d 50000  |e 910000PS102545488X  |e 910100PS102545488X  |e 50000PS102545488X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1944400575  |e 4821378116 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Clinical and economic burden associated with symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy in Germany","title_sort":"Clinical and economic burden associated with symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy in Germany"}],"physDesc":[{"extent":"10 S.","noteIll":"Illustrationen"}],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"506287343","id":{"issn":["1861-0692"],"zdb":["2218331-0"],"eki":["506287343"]},"origin":[{"dateIssuedKey":"2006","publisherPlace":"Berlin","dateIssuedDisp":"2006-","publisher":"Springer"}],"disp":"Clinical and economic burden associated with symptomatic and asymptomatic obstructive hypertrophic cardiomyopathy in GermanyClinical research in cardiology","language":["eng"],"pubHistory":["95.2006 -"],"part":{"pages":"1-10","text":"(2025), Seite 1-10","year":"2025","extent":"10"},"title":[{"title_sort":"Clinical research in cardiology","title":"Clinical research in cardiology"}],"physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"27 October 2025"}],"name":{"displayForm":["Farbod Sedaghat-Hamedani, Carla L. Zema, Michael Schultze, Tarcyane B. Garcia, Nils Kossack, Julia Borchert, Ervant J. Maksabedian Hernandez, Yue Zhong, Tobias Bluhmki, Taryn Krause, Johanna Schmoelders, Benjamin Meder"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1007/s00392-025-02776-4"],"eki":["1944400575"]},"recId":"1944400575","person":[{"family":"Sedaghat-Hamedani","role":"aut","display":"Sedaghat-Hamedani, Farbod","given":"Farbod"},{"display":"Zema, Carla L.","family":"Zema","role":"aut","given":"Carla L."},{"role":"aut","family":"Schultze","display":"Schultze, Michael","given":"Michael"},{"role":"aut","family":"Garcia","display":"Garcia, Tarcyane B.","given":"Tarcyane B."},{"given":"Nils","role":"aut","family":"Kossack","display":"Kossack, Nils"},{"role":"aut","family":"Borchert","display":"Borchert, Julia","given":"Julia"},{"given":"Ervant J.","role":"aut","family":"Maksabedian Hernandez","display":"Maksabedian Hernandez, Ervant J."},{"family":"Zhong","role":"aut","display":"Zhong, Yue","given":"Yue"},{"given":"Tobias","display":"Bluhmki, Tobias","family":"Bluhmki","role":"aut"},{"given":"Taryn","display":"Krause, Taryn","role":"aut","family":"Krause"},{"given":"Johanna","role":"aut","family":"Schmoelders","display":"Schmoelders, Johanna"},{"family":"Meder","role":"aut","display":"Meder, Benjamin","given":"Benjamin"}],"language":["eng"],"note":["Online veröffentlicht: 27. Oktober 2025","Gesehen am 04.12.2025"]} 
SRT |a SEDAGHATHACLINICALAN2720